Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Taiwan Opens New Center For Phase I, II Drug Trials

This article was originally published in PharmAsia News

Executive Summary

Taiwan has opened a university hospital center dedicated to conducting early-stage clinical trials of drugs, with an emphasis on cancer treatments. The National Health Research institutes and the National Cheng Kung University Hospital formed the project to conduct Phase I and Phase II trials. Taiwanese and foreign pharmaceutical companies together already have commissioned the center to conduct trials on about 40 cancer drugs they want to test, about one-fifth of them from local firms. (Click here for more



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts